FANJ
TVRD

Financial Architects (New Jersey)’s Tvardi Therapeutics TVRD Stock Holding History

Financial Architects (New Jersey)’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6
Closed -$3K – 791
2020
Q2 		$3K Hold
6
– – ﹤0.01% 788
2020
Q1 		$3K Hold
6
– – ﹤0.01% 761
2019
Q4 		$3K Hold
6
– – ﹤0.01% 823
2019
Q3 		$4K Hold
6
– – ﹤0.01% 862
2019
Q2 		$4K Hold
6
– – ﹤0.01% 1044
2019
Q1 		$4K Buy
+6
New +$3.59K ﹤0.01% 1269
2018
Q4 		– Sell
-14
Closed -$12K – 1522
2018
Q3 		$12K Hold
14
– – ﹤0.01% 1080
2018
Q2 		$10K Buy
+14
New +$7.12K ﹤0.01% 998

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Architects (New Jersey)'s TVRD Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Tvardi Therapeutics (TVRD) in Q3 2020, closing a stake of 6 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in TVRD in Q2 2018 and held it in 8 quarters. The position peaked at $12K in Q3 2018. 160 funds tracked by Wall St. Rank hold TVRD as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining Tvardi Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 6 Tvardi Therapeutics shares in Q3 2020, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in Tvardi Therapeutics in Q2 2018 and held it in 8 quarters.
  • Financial Architects (New Jersey)'s Tvardi Therapeutics position peaked at $12K in Q3 2018.
  • 160 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.